These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 416323)

  • 21. Studies on pigment production by Pseudomonas aeruginosa. 3. Crystal of fluorescent substance.
    Osawa S; Yabuuchi E; Narano Y; Feng TY; Yukawa Y
    Jpn J Microbiol; 1965 Sep; 9(3):115-22. PubMed ID: 4957090
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of antibiotics on the process of pigment and toxin formation in Bac. pyocyaneus under experimental conditions].
    Cherkas GP; Morozova NS; Podgornaia LG
    Antibiotiki; 1971 Sep; 16(9):802-5. PubMed ID: 5003157
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiological study of Staphylococcus aureus and Pseudomonas aeruginosa in an intensive care unit].
    Goetz ML; Reeb E; Tulasne PA; Lavillaureix J
    Pathol Microbiol (Basel); 1974; 40(3):191-2. PubMed ID: 4210493
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of methylphosphonic acid on Pseudomonas aerugisa chromogenesis].
    Neuzil E; Lacoste AM; Valette JP; Labeyrie S
    Bull Soc Chim Biol (Paris); 1969 Jul; 51(3):579-89. PubMed ID: 4982277
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical mycobacteria in human disease. Review of literature with report of five strains isolated from cases of pulmonary tuberculosis.
    Rajvanshi VS; Tiagi GK
    Indian J Pathol Bacteriol; 1970 Jan; 13(1):21-9. PubMed ID: 5496978
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological survey of Pseudomonas aeruginosa strains isolated from patients in Canadian hospitals.
    Sato H; Diena BB
    Can J Microbiol; 1974 Apr; 20(4):477-82. PubMed ID: 4208246
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pseudomonas infections (author's transl)].
    Beer K
    Schweiz Rundsch Med Prax; 1978 Aug; 67(35):1276. PubMed ID: 99737
    [No Abstract]   [Full Text] [Related]  

  • 28. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 30. Round table.
    Respiration; 1970; 27():Suppl:199-211. PubMed ID: 4995239
    [No Abstract]   [Full Text] [Related]  

  • 31. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
    J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [L-forms and pigment production in "Pseudomonas aeruginosa" (author's transl)].
    Cerbo M; Vecchione R
    Ann Sclavo; 1978; 20(3):305-11. PubMed ID: 104666
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
    Ramsey DM; Wozniak DJ
    Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection.
    Song Z; Johansen HK; Moser C; Høiby N
    APMIS; 1996 May; 104(5):350-4. PubMed ID: 8703440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype recognition of pyocyanine mutants in pseudomonas aeruginosa.
    Carson M; Jensen RA
    J Bacteriol; 1974 Jan; 117(1):312-4. PubMed ID: 4202997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of medium ingredients on the proteolytic activity and pigmentation of Pseudomonas aeruginosa.
    Tseng CC
    Taiwan Yi Xue Hui Za Zhi; 1975 Jan; 74(1):54-5. PubMed ID: 806654
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pseudomonas aeruginosa circulation in the environment of a surgical hospital and its carrier state among clinical personnel and patients].
    Iskhakova KhI; Vlodavets VV
    Gig Sanit; 1982 May; (5):16-8. PubMed ID: 6807757
    [No Abstract]   [Full Text] [Related]  

  • 40. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice.
    Lau GW; Ran H; Kong F; Hassett DJ; Mavrodi D
    Infect Immun; 2004 Jul; 72(7):4275-8. PubMed ID: 15213173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.